There are many randomized controlled trials comparing outcomes for Percutaneous coronary intervention (PCI) and optimal medical therapy alone (OMT) for stable coronary artery disease patients whereas little is known about medication adherence PCI versus OMT in a setting apart from randomized controlled trials. Although medication adherence in randomized controlled trials like COURAGE is quite high, in real life these rates are lower. In this study of 232 documented CAD (coronary artery disease) patients, we compared statin, beta blocker and ACE-inhibitors adherence during six-month follow-up between patients treated with PCI and those receiving medical therapy alone. Medication adherence was measured by National reimbursement database records Of the 232 patients who survived to the 6-month followup, the prespecified primary end point of percentage of patients adherent by prescription records were 33.8% (n¼27) in OMT group and 53.6% (n¼82) in PCI group, p¼0.004 (Figure 1) . Analysis for the individual medication classes revealed similar results for beta blockers (86.0% in PCI group vs 72.5% in OMT group, p¼0.006) and statins (64.5% in PCI group vs 44.0% in OMT group, p¼0.003). Adherence to ACE inhibitors was also higher in PCI group without statistical significance (77.6% vs 69.3%, p¼0.17). In the present study we demonstrated that medication adherence to evidence based therapies in stable coronary artery disease patients in PCI group is significantly higher than OMT group.
Objectives: Neutrophil/Lymphocyte ratio (NLR) is being increasingly used as a marker for cardiovascular risk assessment and as a prognostic tool in ST-elevated myocardial infarction (STEMI) . In this study, we aimed to investigate the association of the NLR with GRACE risk score and in-hospital major advanced cardiac events in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Material/Methods: We analyzed 101 consecutive STEMI patents treated with primary PCI. Patients were divided into 3 groups by use of GRACE risk score. The NLR was calculated as a part of automated complete blood count. The association between NLR and GRACE risk score was assessed. Results: Baseline Characteristics.
The study population consisted of 101 consecutive STEMI patients. 80.2% of patients were male and mean age of patients was 57.97AE12.24 years. 42 patients were hypertensive,23 patients were diabetic,34 patients were hyperlipidemic and 57 were smoker.
According to the GRACE risk score,21 patients had low GRACE risk scores,48 patients had intermediate GRACE risk scores, 32 patients had high GRACE risk scores. Demographic and biochemical characteristics of patients in GRACE risk score groups are shown in table 1. The NLR showed a proportional increase correlated with GRACE risk score (p<0.001) (Table 1, Figure 1 ).
Correlation With In-Hospital Events During the in-hospital period, 11 patients (10.9%) presented cardiac events (3 cardiac death, 2 reinfarction, 6 new-onset heart failure). These patients had more advanced Killip functional class and higher GRACE risk score. The occurrence of in hospital cardiac death, reinfarction or new-onset heart failure was significantly related to NLR at admission (8.18AE1.16 vs. 3.07AE1.77, p<0.001). Likewise, NLR and GRACE risk score showed a significant positive correlation (r¼0.803, p<0.001) ( Figure 2 ).
Multivariate Analysis For in hospital cardiac events; N/L ratio,blood glucose level upon admission, troponin level at admission and in hospital GRACE death point were analyzed using a multivariate logistic regression model. The NLR was the only independent predictor of in-hospital cardiac events (odds ratio 3.63, confidence interval 95%: 1.31-10.04, p¼0.013) ( Table 2) . Discussion: NLR has recently emerged as a potential new biomarker which singles out individuals at risk for future cardiovascular events in STEMI patients. Unlike many other inflammatory markers and bioassays, NLR is an inexpensive and readily available marker that provides an additional level of risk scores in predicting inhospital and long-term outcomes. Although the GRACE risk score is routinely used for stratification of patients with acute coronary syndrome, NLR may provide additional prognostic value. Increased NLR is independently associated with a higher rate of inhospital cardiac events. The determination of NLR for risk stratification of STEMI patients during hospitalization may be useful. Background and Purpose: In the setting of unstable angina/non-ST-segment elevation acute coronary syndromes (UA/NSTEMI-ACS), diabetes mellitus particularly were found to be an independent predictor of mortality. We present the treatment trends of NSTEMI-ACS in diabetic patients in King Abdulaziz Medical city National Guard Hospital (KAMC) in Jeddah in comparison to the whole Kingdom of Saudi Arabia (KSA). Data are derived from the results of Multicenter International Diabetes -Acute Coronary Syndromes (MIDAS) study. Design: Diabetic patients presenting with UA/NSTEMI-ACS where enrolled into the study at the time of admission to the emergency/coronary care department.
A total of 3624 patients were enrolled in several countries; 35 from KAMCamong total of 142 from KSA. Results: The patients enrolled were 94% type 2 DM in KSA, while in Jeddah,the percentage was 100% and theyhad more prevalent high risk factors.
Glycoprotein IIb/IIIa inhibitors were more utilized appropriately in Jeddah, particularly in the elderly, in comparison to the whole KSA, but less than the recommended guidelines. While the use of Clopedogril / Ticlopidine was similarly high in both populations. Conclusions: The non-invasive approach did not affect the trends of treatment in KAMC. GP IIb/IIIa inhibitors are underutilized in KAMC; however it was more utilized than the whole KSA. Clopedogril / Ticlopidineuse were optimal in both location. Demographic and biochemical characteristics of patients in GRACE risk score groups (Abbreviations: BMI, body mass index; HT, hypertension; DM, diabetes mellitus; HPL, hyperlipidemia; WBC, white blood cell; NLR, neutrophil/lymphocyte ratio y p<0.001 compared with GRACE 108-140 points, z p<0.001 compared with GRACE>140 points, * p<0.001 compared with GRACE<108 points, ** p¼0.007 compared with GRACE<108 points, yy p¼0.01 compared with GRACE<108 points) 
